The Federal Trade Commission (FTC) has requested Immucor to submit documents related to three acquisitions made by the company in the period 1996-99. FTC is investigating if Immucor violated federal antitrust laws in these deals.
Immucor announced its Q1 results, which exceeded analysts’ expectations. The net income for the quarter was $17.8 million; an increase of 39 percent compared to $12.7 million last year. Further, the sales increased by 25 percent to $63.63 million compared to $51.04 million last year. The increase in profit was mainly driven by volume and price increases in the U.S.